Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.010
+0.080 (2.73%)
Mar 31, 2025, 1:27 PM EDT - Market open
Atea Pharmaceuticals Employees
Atea Pharmaceuticals had 56 employees as of December 31, 2024. The number of employees decreased by 19 or -25.33% compared to the previous year.
Employees
56
Change (1Y)
-19
Growth (1Y)
-25.33%
Revenue / Employee
n/a
Profits / Employee
-$3,006,875
Market Cap
257.43M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56 | -19 | -25.33% |
| Dec 31, 2023 | 75 | 5 | 7.14% |
| Dec 31, 2022 | 70 | 11 | 18.64% |
| Dec 31, 2021 | 59 | 20 | 51.28% |
| Dec 31, 2020 | 39 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
AVIR News
- 4 days ago - Atea Pharmaceuticals Highlights Actions Underway to Enhance Shareholder Value - GlobeNewsWire
- 5 days ago - The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors - Business Wire
- 9 days ago - Atea Pharmaceuticals Issues Statement Regarding Director Nominations - GlobeNewsWire
- 12 days ago - Atea Pharmaceuticals Announces Presentation of Bemnifosbuvir Preclinical Data at the 38th International Conference on Antiviral Research (ICAR) 2025 - GlobeNewsWire
- 24 days ago - Atea Pharmaceuticals, Inc. (AVIR) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 24 days ago - Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 4 weeks ago - Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Financial Results Conference Call on March 6, 2025 - GlobeNewsWire
- 5 weeks ago - Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors - GlobeNewsWire